Previous Close | $50.86 |
Intrinsic Value | $270.97 |
Upside potential | +433% |
Data is not available at this time.
Trupanion, Inc. operates in the pet insurance industry, providing medical insurance for cats and dogs primarily in North America. The company’s core revenue model is subscription-based, with recurring premiums from pet owners and partnerships with veterinary practices. Trupanion differentiates itself through direct payment to veterinarians, reducing out-of-pocket expenses for pet owners. The pet insurance market is growing due to rising pet ownership and increasing veterinary costs, positioning Trupanion as a key player in this niche. The company’s technology-driven approach and focus on customer retention strengthen its competitive edge. Trupanion’s market position is further bolstered by its scalable platform and expanding network of veterinary partners, which enhance its ability to capture market share in a fragmented industry.
Trupanion reported revenue of $1.29 billion for FY 2024, reflecting steady growth in its subscription base. However, the company posted a net loss of $9.6 million, with diluted EPS of -$0.23, indicating ongoing challenges in achieving profitability. Operating cash flow was positive at $48.3 million, suggesting efficient cash generation from core operations. Capital expenditures totaled $9.7 million, highlighting moderate reinvestment needs.
The company’s earnings power remains constrained by high customer acquisition costs and claims expenses, common in the insurance sector. Trupanion’s capital efficiency is supported by its scalable platform, which allows for incremental revenue growth without proportional cost increases. The positive operating cash flow demonstrates the company’s ability to fund operations internally, though profitability improvements are needed to enhance long-term sustainability.
Trupanion’s balance sheet shows $160.3 million in cash and equivalents, providing liquidity for near-term obligations. Total debt stands at $128.9 million, resulting in a manageable leverage position. The company’s financial health is stable, with sufficient liquidity to support growth initiatives and weather potential volatility in claims costs. No dividends were paid, aligning with its focus on reinvesting cash flows into expansion.
Trupanion’s revenue growth reflects increasing adoption of pet insurance, driven by rising pet healthcare costs. The company has not issued dividends, prioritizing reinvestment in technology, marketing, and partnerships to capture market share. Growth trends are favorable, but profitability remains a key hurdle. The absence of a dividend policy is consistent with its growth-stage focus and capital allocation strategy.
The market values Trupanion based on its growth potential in the expanding pet insurance sector. Investors likely focus on subscriber growth and margin improvement prospects rather than near-term profitability. Valuation metrics may reflect optimism about the company’s ability to scale efficiently and achieve sustainable profitability over time, though execution risks remain.
Trupanion’s strategic advantages include its proprietary software, which streamlines claims processing and enhances customer experience. The company’s outlook depends on its ability to balance growth with profitability, leveraging its scalable model. Long-term success will hinge on expanding its veterinary network and controlling claims costs. Industry tailwinds support growth, but competitive pressures and regulatory risks could pose challenges.
Company filings, investor presentations
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |